Skip to content

Clinical trials

Carcinoma in Situ trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma in Situ Country / region: Canada Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20101
20152
20171
20201
20212
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Completed3
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bioniche Life Sciences Inc.2
Children's Oncology Group2
Astellas Pharma Global Development, Inc.1
CG Oncology, Inc.1
Cell Genesys1
McGill University1
Merck Sharp & Dohme LLC1
Protara Therapeutics1
enGene, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma in Situ11
Urinary Bladder Neoplasms7
Non-Muscle Invasive Bladder Neoplasms6
Carcinoma, Transitional Cell4
Mycobacterium Infections2
Neoplasm Recurrence, Local2
Neoplasms2
Adenoviridae Infections1
Central Nervous System Neoplasms1
Desmoid Tumors1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.